HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis

Julio Madrigal-Matute, Carlos Ernesto Fernandez-Garcia, Carmen Gomez-Guerrero, Oscar Lopez-Franco, Begoña Muñoz-Garcia, Jesus Egido, Luis Miguel Blanco-Colio, Jose Luis Martin-Ventura

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Aims Reactive oxygen species (ROS) participate in atherogenesis through different mechanisms including oxidative stress and inflammation. Proteins implicated in both processes, such as mitogen-activated protein kinase kinase (MEK) and some NADPH oxidase (NOX) subunits, are heat shock protein-90 (HSP90) client proteins. In this work, we investigated the antioxidant properties of the HSP90 inhibitor, 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in experimental atherosclerosis. Methods and results Treatment of ApoE -/- mice with 17-DMAG (2 mg/kg every 2 days for 10 weeks) decreased ROS levels and extracellular signal-regulated kinase (ERK) activation in aortic plaques compared with control animals. Accordingly, treatment of rat vascular smooth muscle cells (VSMCs) with 17-DMAG increased HSP27 and HSP70 and inhibited ERK activation. Interestingly, 17-DMAG diminished NADPH oxidase dependent ROS production in VSMCs and monocytes. In addition, a marked reduction in NADPH oxidase dependent ROS production was observed with HSP90siRNA and the opposite pattern with HSP70siRNA. 17-DMAG also diminished the expression of Nox1 and Nox organizer-1 (Noxo1) in VSMCs and monocytes. Interestingly, 17-DMAG was able to modulate ROS-induced monocyte to macrophage differentiation. Finally, higher expression of Nox1 and Noxo1 was found in the inflammatory region of human atherosclerotic plaques, colocalizing with VSMCs, macrophages, and ROS-producing cells. Conclusion Our results suggest that HSP90 inhibitors interfere with oxidative stress and modulate experimental atherosclerosis development through reduction in pro-oxidative factors. Published on behalf of the European Society of Cardiology. All rights reserved.

Original languageEnglish (US)
Pages (from-to)116-123
Number of pages8
JournalCardiovascular research
Volume95
Issue number1
DOIs
StatePublished - Jul 1 2012
Externally publishedYes

Fingerprint

17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
HSP90 Heat-Shock Proteins
Reactive Oxygen Species
Atherosclerosis
Oxidative Stress
Vascular Smooth Muscle
Smooth Muscle Myocytes
NADPH Oxidase
Monocytes
Mitogen-Activated Protein Kinase Kinases
Extracellular Signal-Regulated MAP Kinases
Macrophages
Apolipoproteins E
Atherosclerotic Plaques
Proteins
Antioxidants
Inflammation

Keywords

  • Atherosclerosis
  • HSP90 inhibitors
  • Nox1
  • Noxo1
  • Oxidative stress

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Physiology

Cite this

Madrigal-Matute, J., Fernandez-Garcia, C. E., Gomez-Guerrero, C., Lopez-Franco, O., Muñoz-Garcia, B., Egido, J., ... Martin-Ventura, J. L. (2012). HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis. Cardiovascular research, 95(1), 116-123. https://doi.org/10.1093/cvr/cvs158

HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis. / Madrigal-Matute, Julio; Fernandez-Garcia, Carlos Ernesto; Gomez-Guerrero, Carmen; Lopez-Franco, Oscar; Muñoz-Garcia, Begoña; Egido, Jesus; Blanco-Colio, Luis Miguel; Martin-Ventura, Jose Luis.

In: Cardiovascular research, Vol. 95, No. 1, 01.07.2012, p. 116-123.

Research output: Contribution to journalArticle

Madrigal-Matute, J, Fernandez-Garcia, CE, Gomez-Guerrero, C, Lopez-Franco, O, Muñoz-Garcia, B, Egido, J, Blanco-Colio, LM & Martin-Ventura, JL 2012, 'HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis', Cardiovascular research, vol. 95, no. 1, pp. 116-123. https://doi.org/10.1093/cvr/cvs158
Madrigal-Matute J, Fernandez-Garcia CE, Gomez-Guerrero C, Lopez-Franco O, Muñoz-Garcia B, Egido J et al. HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis. Cardiovascular research. 2012 Jul 1;95(1):116-123. https://doi.org/10.1093/cvr/cvs158
Madrigal-Matute, Julio ; Fernandez-Garcia, Carlos Ernesto ; Gomez-Guerrero, Carmen ; Lopez-Franco, Oscar ; Muñoz-Garcia, Begoña ; Egido, Jesus ; Blanco-Colio, Luis Miguel ; Martin-Ventura, Jose Luis. / HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis. In: Cardiovascular research. 2012 ; Vol. 95, No. 1. pp. 116-123.
@article{f4bdf89db5d34bed85a3452f14edfefc,
title = "HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis",
abstract = "Aims Reactive oxygen species (ROS) participate in atherogenesis through different mechanisms including oxidative stress and inflammation. Proteins implicated in both processes, such as mitogen-activated protein kinase kinase (MEK) and some NADPH oxidase (NOX) subunits, are heat shock protein-90 (HSP90) client proteins. In this work, we investigated the antioxidant properties of the HSP90 inhibitor, 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in experimental atherosclerosis. Methods and results Treatment of ApoE -/- mice with 17-DMAG (2 mg/kg every 2 days for 10 weeks) decreased ROS levels and extracellular signal-regulated kinase (ERK) activation in aortic plaques compared with control animals. Accordingly, treatment of rat vascular smooth muscle cells (VSMCs) with 17-DMAG increased HSP27 and HSP70 and inhibited ERK activation. Interestingly, 17-DMAG diminished NADPH oxidase dependent ROS production in VSMCs and monocytes. In addition, a marked reduction in NADPH oxidase dependent ROS production was observed with HSP90siRNA and the opposite pattern with HSP70siRNA. 17-DMAG also diminished the expression of Nox1 and Nox organizer-1 (Noxo1) in VSMCs and monocytes. Interestingly, 17-DMAG was able to modulate ROS-induced monocyte to macrophage differentiation. Finally, higher expression of Nox1 and Noxo1 was found in the inflammatory region of human atherosclerotic plaques, colocalizing with VSMCs, macrophages, and ROS-producing cells. Conclusion Our results suggest that HSP90 inhibitors interfere with oxidative stress and modulate experimental atherosclerosis development through reduction in pro-oxidative factors. Published on behalf of the European Society of Cardiology. All rights reserved.",
keywords = "Atherosclerosis, HSP90 inhibitors, Nox1, Noxo1, Oxidative stress",
author = "Julio Madrigal-Matute and Fernandez-Garcia, {Carlos Ernesto} and Carmen Gomez-Guerrero and Oscar Lopez-Franco and Bego{\~n}a Mu{\~n}oz-Garcia and Jesus Egido and Blanco-Colio, {Luis Miguel} and Martin-Ventura, {Jose Luis}",
year = "2012",
month = "7",
day = "1",
doi = "10.1093/cvr/cvs158",
language = "English (US)",
volume = "95",
pages = "116--123",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis

AU - Madrigal-Matute, Julio

AU - Fernandez-Garcia, Carlos Ernesto

AU - Gomez-Guerrero, Carmen

AU - Lopez-Franco, Oscar

AU - Muñoz-Garcia, Begoña

AU - Egido, Jesus

AU - Blanco-Colio, Luis Miguel

AU - Martin-Ventura, Jose Luis

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Aims Reactive oxygen species (ROS) participate in atherogenesis through different mechanisms including oxidative stress and inflammation. Proteins implicated in both processes, such as mitogen-activated protein kinase kinase (MEK) and some NADPH oxidase (NOX) subunits, are heat shock protein-90 (HSP90) client proteins. In this work, we investigated the antioxidant properties of the HSP90 inhibitor, 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in experimental atherosclerosis. Methods and results Treatment of ApoE -/- mice with 17-DMAG (2 mg/kg every 2 days for 10 weeks) decreased ROS levels and extracellular signal-regulated kinase (ERK) activation in aortic plaques compared with control animals. Accordingly, treatment of rat vascular smooth muscle cells (VSMCs) with 17-DMAG increased HSP27 and HSP70 and inhibited ERK activation. Interestingly, 17-DMAG diminished NADPH oxidase dependent ROS production in VSMCs and monocytes. In addition, a marked reduction in NADPH oxidase dependent ROS production was observed with HSP90siRNA and the opposite pattern with HSP70siRNA. 17-DMAG also diminished the expression of Nox1 and Nox organizer-1 (Noxo1) in VSMCs and monocytes. Interestingly, 17-DMAG was able to modulate ROS-induced monocyte to macrophage differentiation. Finally, higher expression of Nox1 and Noxo1 was found in the inflammatory region of human atherosclerotic plaques, colocalizing with VSMCs, macrophages, and ROS-producing cells. Conclusion Our results suggest that HSP90 inhibitors interfere with oxidative stress and modulate experimental atherosclerosis development through reduction in pro-oxidative factors. Published on behalf of the European Society of Cardiology. All rights reserved.

AB - Aims Reactive oxygen species (ROS) participate in atherogenesis through different mechanisms including oxidative stress and inflammation. Proteins implicated in both processes, such as mitogen-activated protein kinase kinase (MEK) and some NADPH oxidase (NOX) subunits, are heat shock protein-90 (HSP90) client proteins. In this work, we investigated the antioxidant properties of the HSP90 inhibitor, 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in experimental atherosclerosis. Methods and results Treatment of ApoE -/- mice with 17-DMAG (2 mg/kg every 2 days for 10 weeks) decreased ROS levels and extracellular signal-regulated kinase (ERK) activation in aortic plaques compared with control animals. Accordingly, treatment of rat vascular smooth muscle cells (VSMCs) with 17-DMAG increased HSP27 and HSP70 and inhibited ERK activation. Interestingly, 17-DMAG diminished NADPH oxidase dependent ROS production in VSMCs and monocytes. In addition, a marked reduction in NADPH oxidase dependent ROS production was observed with HSP90siRNA and the opposite pattern with HSP70siRNA. 17-DMAG also diminished the expression of Nox1 and Nox organizer-1 (Noxo1) in VSMCs and monocytes. Interestingly, 17-DMAG was able to modulate ROS-induced monocyte to macrophage differentiation. Finally, higher expression of Nox1 and Noxo1 was found in the inflammatory region of human atherosclerotic plaques, colocalizing with VSMCs, macrophages, and ROS-producing cells. Conclusion Our results suggest that HSP90 inhibitors interfere with oxidative stress and modulate experimental atherosclerosis development through reduction in pro-oxidative factors. Published on behalf of the European Society of Cardiology. All rights reserved.

KW - Atherosclerosis

KW - HSP90 inhibitors

KW - Nox1

KW - Noxo1

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84862905692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862905692&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvs158

DO - 10.1093/cvr/cvs158

M3 - Article

C2 - 22547655

AN - SCOPUS:84862905692

VL - 95

SP - 116

EP - 123

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 1

ER -